Casdin Capital as of June 30, 2023
Portfolio Holdings for Casdin Capital
Casdin Capital holds 41 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biolife Solutions Com New (BLFS) | 14.9 | $171M | 7.7M | 22.10 | |
| Sarepta Therapeutics (SRPT) | 10.2 | $116M | 1.0M | 114.52 | |
| Relay Therapeutics (RLAY) | 6.6 | $75M | 6.0M | 12.56 | |
| Eqrx | 6.4 | $74M | 40M | 1.86 | |
| Alnylam Pharmaceuticals (ALNY) | 4.6 | $53M | 280k | 189.94 | |
| Intellia Therapeutics (NTLA) | 4.5 | $52M | 1.3M | 40.78 | |
| Revolution Medicines (RVMD) | 4.2 | $48M | 1.8M | 26.75 | |
| EXACT Sciences Corporation (EXAS) | 4.1 | $47M | 500k | 93.90 | |
| Verve Therapeutics (VERV) | 3.9 | $44M | 2.4M | 18.75 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 3.6 | $41M | 997k | 41.57 | |
| Blueprint Medicines (BPMC) | 3.4 | $39M | 620k | 63.20 | |
| Denali Therapeutics (DNLI) | 3.4 | $38M | 1.3M | 29.51 | |
| Tenaya Therapeutics (TNYA) | 3.3 | $38M | 6.4M | 5.87 | |
| Catalent | 2.7 | $31M | 720k | 43.36 | |
| Pliant Therapeutics (PLRX) | 2.7 | $31M | 1.7M | 18.12 | |
| Somalogic Class A Com | 2.5 | $29M | 13M | 2.31 | |
| Illumina (ILMN) | 2.5 | $29M | 155k | 187.49 | |
| Maxcyte (MXCT) | 1.9 | $22M | 4.7M | 4.59 | |
| 2seventy Bio Common Stock | 1.8 | $21M | 2.0M | 10.12 | |
| 4d Molecular Therapeutics In (FDMT) | 1.7 | $19M | 1.1M | 18.07 | |
| Genedx Holdings Corp Com Cl A (WGS) | 1.6 | $18M | 3.1M | 5.96 | |
| Beam Therapeutics (BEAM) | 1.6 | $18M | 570k | 31.93 | |
| Abcellera Biologics (ABCL) | 1.4 | $16M | 2.5M | 6.46 | |
| Century Therapeutics (IPSC) | 0.9 | $10M | 3.2M | 3.16 | |
| Fate Therapeutics (FATE) | 0.9 | $9.8M | 2.1M | 4.76 | |
| Avidity Biosciences Ord (RNA) | 0.8 | $9.4M | 850k | 11.09 | |
| Twist Bioscience Corp (TWST) | 0.8 | $9.2M | 450k | 20.46 | |
| Prime Medicine (PRME) | 0.5 | $5.4M | 367k | 14.65 | |
| Incyte Corporation (INCY) | 0.4 | $4.8M | 78k | 62.25 | |
| Sana Biotechnology (SANA) | 0.4 | $4.5M | 750k | 5.96 | |
| Sage Therapeutics (SAGE) | 0.4 | $4.2M | 90k | 47.02 | |
| Monte Rosa Therapeutics (GLUE) | 0.3 | $3.5M | 511k | 6.85 | |
| Tango Therapeutics (TNGX) | 0.3 | $3.3M | 1.0M | 3.32 | |
| D Fluidigm Corp Del (LAB) | 0.2 | $2.3M | 1.2M | 1.93 | |
| Absci Corp (ABSI) | 0.2 | $2.1M | 1.4M | 1.52 | |
| Exscientia Ads (EXAI) | 0.1 | $1.3M | 214k | 5.92 | |
| Singular Genomics Systems In | 0.1 | $1.1M | 1.3M | 0.83 | |
| Mirati Therapeutics | 0.1 | $860k | 24k | 36.13 | |
| Lianbio Sponsored Ads (LIANY) | 0.0 | $471k | 206k | 2.28 | |
| Kronos Bio | 0.0 | $213k | 124k | 1.72 | |
| Scilex Holding | 0.0 | $131k | 24k | 5.57 |
